POMDOCTOR LIMITED Class A

XNAS

Last traded price · USD

$1.49

+0.68%Delayed · Pre-market

Delayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 06:26 IST · A quote does not mean the product is available to trade on your account.

Day's open: —
Previous close: $1.48
Volume: 301,078
Day's high: —
Day's low: —

In brief

POMDOCTOR LIMITED is a US-listed company listed on Nasdaq, valued at about $4M.
Its shares closed at $1.55 on 4 Nov 2026, down 98.5% over the past year.
From India you can buy POM in US dollars under the RBI's Liberalised Remittance Scheme, including a fraction of one share. See what it costs

Questions investors ask

Can I buy POMDOCTOR LIMITED (POM) shares from India?

Yes. Indian residents can invest in the US stock market under the Reserve Bank of India's Liberalised Remittance Scheme (LRS), which lets a resident individual remit up to USD 250,000 per financial year, across all permitted purposes combined. US-listed stocks and ETFs are a permitted investment under the LRS. You are solely responsible for ensuring your remittances comply with the LRS annual limit, the applicable Tax Collected at Source (TCS) rules, and all reporting requirements, including Schedule FA in your income-tax return.

Do I need the price of a whole POM share to invest?

Yes. You can buy fractional shares, which lets you invest a fixed rupee/dollar amount even in high-priced stocks. For example, if one share trades at USD 1,000 and you invest USD 100, you receive 0.1 of a share.

How much can I invest in US stocks in a year?

Under the LRS, an Indian resident can remit up to USD 250,000 per financial year (April to March) across all permitted purposes combined, from their own funds. This is a per-individual limit set by the RBI.

Can I trade POM options or futures?

No. Under RBI / FEMA rules, the LRS does not permit margin trading or speculative instruments such as futures, options, or other derivatives. Your US account is a cash account, not a derivatives and margin account.

Insights

Quotes run fifteen minutes behind.

Behind SPY over 1 year
1 month: +53.5% (SPY −1.6%). 3 months: +121.4% (SPY −0.4%). 1 year: −98.5% (SPY +13.6%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: POM, SPY · as of 4 Nov 2026
258.0% above its 52-week low
Closed at $1.55 on 4 Nov 2026: 98.7% below the 52-week high of $115.74 (6 Nov 2025) and 258.0% above the low of $0.43 (20 Oct 2026).
Daily price bars, split-adjusted · as of 4 Nov 2026
Above its 50-day average, below its 200-day
The 4 Nov 2026 close of $1.55 was 52.0% above its 50-day average ($1.02) and 45.9% below its 200-day average ($2.87).
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026
22.5K shares sold short
22.5K shares were sold short at the 15 Oct 2026 settlement; covering them would take 1.0 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026

Returns

Price return, split-adjusted

At the 4 Nov 2026 close

1 month+53.5%

6 months−82.6%

1 year−98.5%

5 years—

Newswire

About

Pomdoctor Ltd is an online medical services platform for chronic diseases in China. With a focus on chronic disease management and pharmaceutical services, its business model forms a one-stop platform for medical services, which organically connects patients to doctors and pharmaceutical products. Its experience in tackling chronic diseases can be traced back to the launch of its platform on mobile devices. The company operates in two segments: Internet hospital, and Pharmaceutical supply chain. The majority of its revenue is derived from the Pharmaceutical supply chain segment.

Website

Notable moves

October 21, 2026
+352.77%
May 11, 2026
+97.47%
December 10, 2025
−90.77%

POMDOCTOR LIMITED Class A

XNAS

Last traded price · USD

$1.49

+0.68%Delayed · Pre-market

Delayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 06:26 IST · A quote does not mean the product is available to trade on your account.

Day's open: —
Previous close: $1.48
Volume: 301,078
Day's high: —
Day's low: —

In brief

POMDOCTOR LIMITED is a US-listed company listed on Nasdaq, valued at about $4M.
Its shares closed at $1.55 on 4 Nov 2026, down 98.5% over the past year.
From India you can buy POM in US dollars under the RBI's Liberalised Remittance Scheme, including a fraction of one share. See what it costs

Questions investors ask

Can I buy POMDOCTOR LIMITED (POM) shares from India?

Do I need the price of a whole POM share to invest?

How much can I invest in US stocks in a year?

Can I trade POM options or futures?

Insights

Quotes run fifteen minutes behind.

Behind SPY over 1 year
1 month: +53.5% (SPY −1.6%). 3 months: +121.4% (SPY −0.4%). 1 year: −98.5% (SPY +13.6%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: POM, SPY · as of 4 Nov 2026
258.0% above its 52-week low
Closed at $1.55 on 4 Nov 2026: 98.7% below the 52-week high of $115.74 (6 Nov 2025) and 258.0% above the low of $0.43 (20 Oct 2026).
Daily price bars, split-adjusted · as of 4 Nov 2026
Above its 50-day average, below its 200-day
The 4 Nov 2026 close of $1.55 was 52.0% above its 50-day average ($1.02) and 45.9% below its 200-day average ($2.87).
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026
22.5K shares sold short
22.5K shares were sold short at the 15 Oct 2026 settlement; covering them would take 1.0 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026

Returns

Price return, split-adjusted

At the 4 Nov 2026 close

1 month+53.5%

6 months−82.6%

1 year−98.5%

5 years—

Newswire

About

Website

Notable moves

October 21, 2026
+352.77%
May 11, 2026
+97.47%
December 10, 2025
−90.77%

POMDOCTOR LIMITED Class A

POMDOCTOR LIMITED in brief

Behind SPY over 1 year

258.0% above its 52-week low

Above its 50-day average, below its 200-day

22.5K shares sold short

POMDOCTOR LIMITED Class A

POMDOCTOR LIMITED in brief

Behind SPY over 1 year

258.0% above its 52-week low

Above its 50-day average, below its 200-day

22.5K shares sold short